Probiotics in the Treatment of Colorectal Cancer

Medicines (Basel). 2018 Sep 7;5(3):101. doi: 10.3390/medicines5030101.

Abstract

The human microbiome plays many roles in inflammation, drug metabolism, and even the development of cancer that we are only beginning to understand. Colorectal cancer has been a focus for study in this field as its pathogenesis and its response to treatment have both been linked to the functioning of microbiota. This literature review evaluates the animal and human studies that have explored this relationship. By manipulating the microbiome with interventions such as probiotic administration, we may be able to reduce colorectal cancer risk and improve the safety and effectiveness of cancer therapy even though additional clinical research is still necessary.

Keywords: colorectal cancer; microbiome; microbiota; probiotics; synbiotics.

Publication types

  • Review